Copyright
        ©The Author(s) 2024.
    
    
        World J Gastrointest Oncol. Aug 15, 2024; 16(8): 3496-3506
Published online Aug 15, 2024. doi: 10.4251/wjgo.v16.i8.3496
Published online Aug 15, 2024. doi: 10.4251/wjgo.v16.i8.3496
		Figure 1 Serum ferritin by American Joint Committee on Cancer stage and stratified by sex.
		
			 Stage IV disease was associated with significantly higher serum ferritin levels compared to other stages (P < 0.001), particularly in males compared to females. A: American Joint Committee on Cancer stage; B: Sex; C: The proportion of locally advanced disease (Stage I-III) to advanced disease (Stage IV) by serum ferritin level, demonstrating a higher proportion of patients with early-stage disease with serum ferritin < 20 ng/mL compared to those with advanced disease. The stars (*) denote outliers and are standard when developing figures in SPSS.
		
	
		Figure 2 Serum ferritin.
		
			 A: After accounting for stage at diagnosis, serum ferritin in females was significantly positively correlated with age (r = 0.391; P = 0.009). However, this correlation was not observed in males (r = 0.086; P = 0.618); B: Serum ferritin by month obtained from colorectal cancer diagnosis, stratified by the stage of the disease, demonstrating a positive correlation between serum ferritin and a later time to ascertainment.
		
	
- Citation: Urback AL, Martens K, McMurry HS, Chen EY, Citti C, Sharma A, Kardosh A, Shatzel JJ. Serum ferritin and the risk of early-onset colorectal cancer. World J Gastrointest Oncol 2024; 16(8): 3496-3506
- URL: https://www.wjgnet.com/1948-5204/full/v16/i8/3496.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i8.3496

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                         
                         
			